Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/13/1996 | US5545634 Therapy, prevention of breast and endometrial cancer |
08/13/1996 | US5545628 Pharmaceutical composition containing fenofibrate |
08/13/1996 | US5545615 A method of inhibiting fertilization by alpha-1-antitrypsin or antithrombin III |
08/13/1996 | US5545557 Water insoluble coloring agent |
08/13/1996 | US5545442 Mixing a cellulose with a photosensitive catalyst; compression coating; exposure to electromagnetic energy source |
08/13/1996 | US5545423 Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
08/13/1996 | US5545414 Cholesterol lowering food product |
08/13/1996 | US5545413 Dosage form for administering oral hypoglycemic glipizide |
08/13/1996 | US5545412 Using lipophilic compounds to transfect dna and for drug delivery by forming complexes to penetrate cellular membranes |
08/13/1996 | US5545410 Method of controlling the release of carbohydrates by encapsulation and composition therefor |
08/13/1996 | US5545409 Shaped matrix of polyanhydride or polyorthoester and a chondrogenic or osteogenic bioactive protein |
08/13/1996 | US5545408 Containing lutenizing hormone releasing hormone agonist |
08/13/1996 | US5545401 Prevents sexually transmitted diseases; introduced to vagina, prior to intercourse in the form of gel or foam |
08/13/1996 | US5545395 Method of imaging using encapsulated magnetite particles |
08/13/1996 | US5545223 Ported tissue implant systems and methods of using same |
08/13/1996 | CA2112501C Therapeutic composition for treating ent disorders |
08/11/1996 | CA2169247A1 Pharmaceutical compositions and method for the treatment of patients having fragile x syndrome and retarded maturities or affected by alzheimer's type diseases or huntington's chorea or who show similar symptoms of muscular hypotonie and similar s ates |
08/08/1996 | WO1996023522A1 Treatment of diabetic neuropathy |
08/08/1996 | WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof |
08/08/1996 | WO1996023510A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection |
08/08/1996 | WO1996023507A1 Sucralfate preparation |
08/08/1996 | WO1996023505A1 Inhibition of the degradation of connective tissue matrix protein components in mammals |
08/08/1996 | WO1996023500A1 New stable ganelic formulations containing an acid-labile benzimidazol compound, and production process |
08/08/1996 | WO1996023499A1 Extended-release solid oral dosage forms of drugs having low solubility in water |
08/08/1996 | WO1996023498A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
08/08/1996 | WO1996023496A1 Use of melatonin for treating patients suffering from drug addiction |
08/08/1996 | WO1996023494A1 Oral compositions of h2-antagonists |
08/08/1996 | WO1996023493A1 New pharmaceutical composition containing trimebutine and preparation process |
08/08/1996 | WO1996023492A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin |
08/08/1996 | WO1996023491A1 Solid substances comprising valproic acid and sodium valproate |
08/08/1996 | WO1996023490A1 Formulations and methods for reducing skin irritation |
08/08/1996 | WO1996023488A1 Medicament form for the delivery of active substances to wounds |
08/08/1996 | WO1996023487A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof |
08/08/1996 | WO1996023486A1 Taste masking liquids |
08/08/1996 | WO1996023485A1 Carrier particles for use in dry powder inhalers |
08/08/1996 | WO1996023463A1 Transdermal formulation |
08/08/1996 | WO1996023414A1 Properties of cats' facial pheromones |
08/08/1996 | WO1996023409A1 Micellar nanoparticles |
08/08/1996 | DE19503338A1 Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung Dosage form for the delivery of collagenase to wounds and methods for their preparation |
08/08/1996 | DE19503336A1 Arzneiform zur Abgabe von Wirkstoffen an Wunden Dosage form for the delivery of active substances to wounds |
08/08/1996 | CA2212127A1 Formulations and methods for reducing skin irritation |
08/08/1996 | CA2212059A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof |
08/08/1996 | CA2212046A1 Sucralfate preparations |
08/08/1996 | CA2211916A1 New pharmaceutical composition containing trimebutine and preparation process |
08/08/1996 | CA2211783A1 Inhibition of the degradation of connective tissue matrix protein components in mammals |
08/08/1996 | CA2211586A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection___________________________________________ |
08/08/1996 | CA2211450A1 Treatment of diabetic neuropathy |
08/08/1996 | CA2210711A1 Transdermal formulation |
08/07/1996 | EP0724886A1 Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation |
08/07/1996 | EP0724885A1 Pernasal composition and pernasal preparation containing the same |
08/07/1996 | EP0724880A1 Procedure for encapsulating chlorpheniramine |
08/07/1996 | EP0724877A1 Mixture of fenofibrate and vitamin E and its therapeutic use |
08/07/1996 | EP0724876A2 Siloxane MQ resin vesicles and entrapment |
08/07/1996 | EP0724832A1 Properties of cats' facial pheromones |
08/07/1996 | EP0724581A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
08/07/1996 | EP0724452A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND $g(a)-TOCOPHEROL |
08/07/1996 | EP0724449A1 Preservative for pharmaceutical products |
08/07/1996 | EP0724448A1 Senna dosage form |
08/07/1996 | EP0724442A1 Method for the preparation of quinolone-containing oral compositions |
08/07/1996 | EP0724441A1 Picosulphate dosage form |
08/07/1996 | EP0724434A1 Multiple unit tableted dosage form containing proton pump inhibitor |
08/07/1996 | EP0724433A1 Method for preparing microspheres comprising a fluidized bed drying step |
08/07/1996 | EP0724432A1 Methods and compositions for microencapsulation of antigens for use as vaccines |
08/07/1996 | EP0724431A1 Methods and compositions for microencapsulation of adjuvants |
08/07/1996 | EP0724430A1 Method for the formation of liposomes and compositions for use therein |
08/07/1996 | EP0724428A1 Preparation of medical devices by solid free-form fabrication methods |
08/07/1996 | EP0724427A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
08/07/1996 | EP0689429B1 Cross-linked amylose as a binder/disintegrant in tablets |
08/07/1996 | EP0688166A4 Proteinaceous oil spill dispersant |
08/07/1996 | EP0662822A4 Two-phase matrix for sustained release drug delivery device. |
08/07/1996 | CN1128496A Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
08/07/1996 | CN1128495A Pharmaceutical compositions for hardly soluble active substances |
08/07/1996 | CN1128167A Instant Chinese caterpillar fungus powder and its product |
08/07/1996 | CN1128166A Capsule for treatment of dysentery diarrhea and its preparing method |
08/07/1996 | CN1128165A Medicinal towel (plaster) for hyperosteogenia |
08/07/1996 | CN1128164A Chinese herb medicine powder for rhinitis |
08/07/1996 | CN1128163A Dietotherapeutical medicine for adjuvant treatment of hepatitis |
08/07/1996 | CN1128162A Preparation of granula for tonifying kidney and hairs |
08/07/1996 | CN1128157A Yuganwan pill-medicine for hepatitis |
08/07/1996 | CN1128156A Bidouling-medicine for nasosinusitis and its preparation |
08/07/1996 | CN1128155A Yuganwan-medicinal pill for hepatitis |
08/07/1996 | CN1128152A Traditional Chinese medical ointment and lozenge for treatment of psoriasis |
08/07/1996 | CN1128149A Medicine for treating dermatitis |
08/07/1996 | CN1128145A Medicinal powder for treatment of chronic ulcerative colitis |
08/07/1996 | CN1128142A Gepirone dosage form |
08/07/1996 | CN1128141A Duloxetine enteric pellets |
08/07/1996 | CN1032469C Method for processing heterocyclic amide derivant new physical morphogenesis |
08/06/1996 | US5543513 Trehalose desiccant product and dehydration therewith |
08/06/1996 | US5543441 Implants coated with collagen-polymer conjugates |
08/06/1996 | US5543434 Nasal administration of ketamine to manage pain |
08/06/1996 | US5543432 Application of trace elements to animals |
08/06/1996 | US5543430 Method and formulation of stimulating nitric oxide synthesis |
08/06/1996 | US5543422 Heterocyclic amines |
08/06/1996 | US5543418 Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements |
08/06/1996 | US5543408 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
08/06/1996 | US5543399 Cystic fibrosis transmembrane conductance regulator (CFTR) protein |
08/06/1996 | US5543394 Bone morphogenetic protein 5(BMP-5) compositions |
08/06/1996 | US5543393 Blend with a nonionic surfactant |
08/06/1996 | US5543391 Covalent microparticle-drug conjugates for biological targeting |
08/06/1996 | US5543390 Comprising a biologically-active compound including an antimicrobial drug. a microparticle and a cleavable linker moiety |